Clinical Trials
- Heart/Cardiovascular
TARGET BP I Clinical Trial (TARGET BP I)
- Ages18 years - 80 years
- GenderBoth
- Heart/Cardiovascular, Genetics
Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD (ASCENT ASD)
- Ages84 years and younger
- GenderBoth
- Heart/Cardiovascular
Women FiRST: Fractional Flow Reserve and Instantaneous Free-wave Ratio Revascularization Strategies in Women
- Heart/Cardiovascular
Double blind randomized autologous stem cell trial treatment for peripheral arterial disease (PAD) with critical limb threatening ischemia
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
INSPIRE Pipelineā¢ Shield Post Approval Study
- Ages22 years and older
- GenderBoth
- Heart/Cardiovascular
Network for Cardiothoracic Surgical Investigations in Cardiovascular Medicine: Anticoagulation for New-Onset Post-Operative Atrial Fibrillation after CABG (PACES)
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Pragmatic Trial Of Alerts for Use of Mineralocorticoid Receptor Antagonists (PROMPT-MRA)
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
A Phase 2a Study of LAM-001 for the Treatment of Pulmonary Hypertension
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)
- Ages18 years and older
- GenderBoth